Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Other financing activities (2016 - 2024)

Mimedx's Other financing activities history spans 6 years, with the latest figure at -$1.2 million for Q4 2024.

  • For Q4 2024, Other financing activities changed N/A year-over-year to -$1.2 million; the TTM value through Sep 2025 reached -$1.2 million, down 205.18%, while the annual FY2024 figure was -$57000.0, N/A changed from the prior year.
  • Other financing activities for Q4 2024 was -$1.2 million at Mimedx, down from $1.1 million in the prior quarter.
  • Across five years, Other financing activities topped out at $6.5 million in Q3 2020 and bottomed at -$3.3 million in Q4 2020.